Developing personalized T-cell therapies based on cancer cell mutations and immune system type faces challenges in manufacturing cost and feasibility.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.